VPN for Clinical Researchers and Study Coordinators: Protecting Trial Data in the Field

Also on CyberFence: CyberFence's industry directory for other professions · CyberFence for Teams for business VPN with BAA and SSO .

Clinical researchers and study coordinators occupy a unique position in healthcare data security: they handle some of the most sensitive patient data in existence — trial participants' medical histories, diagnoses, treatment responses, adverse events, and genomic data — while working across a patchwork of network environments that includes hospital systems, academic research facilities, sponsor sites, CRO offices, and home offices. Every environment has different security infrastructure, and clinical research doesn't stop between locations.

The regulatory framework governing clinical trial data security is substantial. HIPAA covers PHI collected during clinical trials. FDA 21 CFR Part 11 establishes electronic record and electronic signature requirements for clinical data. ICH E6(R3) Good Clinical Practice (GCP) guidelines address data integrity and confidentiality. EU clinical trials regulation applies to studies with European sites. Together, these frameworks create clear obligations around protecting trial data in transit — obligations that extend to how study coordinators and researchers access electronic data capture (EDC) systems from off-site locations.

What Clinical Researchers Access in the Field

A study coordinator or clinical research associate (CRA) accessing data remotely may be working with:

• Electronic Data Capture (EDC) systems — Medidata Rave, REDCap, Oracle Clinical One, Veeva Vault, and others. These systems contain the complete subject record: enrollment data, visit documentation, lab results, adverse events, and protocol deviations. Access credentials for these systems provide the user with visibility into protected health information for all enrolled subjects.
• Electronic Trial Master File (eTMF) — regulatory documents, consent forms, protocol amendments, and investigator information maintained in platforms like Veeva Vault, Forte Research, and Generis CARA.
• Safety databases — adverse event reporting systems where serious adverse events and unexpected serious adverse reactions (SAEs/SUSARs) are documented and submitted to regulatory authorities. These records contain detailed individual patient medical information.
• Site management systems — CTMS platforms used for patient enrollment tracking, visit scheduling, and study management, often containing identifying information for enrolled participants.
• Remote monitoring platforms — systems like Veeva SiteConnect or Vault CTMS used for remote source data verification (rSDV), which involves accessing actual patient records to verify transcribed data.

Remote source data verification became significantly more common after the COVID-19 pandemic normalized decentralized and hybrid clinical trial models. Study coordinators and CRAs now frequently access patient records and EDC systems from locations outside the traditional sponsor or site network — including home offices, hotels during site visits, and academic institutional networks with varying security configurations.

HIPAA and Clinical Trial Data

Clinical trials that involve patient data collected from covered entities (hospitals, clinics, health systems) are subject to HIPAA. Clinical research organizations that serve as business associates to covered entity sponsors must maintain HIPAA-compliant security practices, including encryption of PHI in transit.

When a study coordinator accesses an EDC system containing subject PHI from a home network or a hotel room, that transmission requires encryption under HIPAA's Security Rule transmission security standard (45 CFR §164.312(e)(1)). Home networks and hotel Wi-Fi are open networks for HIPAA purposes — the covered entity or business associate doesn't control them and can't verify their security configuration.

A VPN creates an encrypted tunnel for EDC sessions, remote source data access, and safety database connections regardless of the underlying network. The PHI in transit is encrypted from the device to the VPN server, satisfying the Security Rule transmission security requirement for connections made outside managed institutional networks.

21 CFR Part 11 and Data Integrity

FDA's 21 CFR Part 11 establishes requirements for electronic records and electronic signatures in clinical research regulated by the FDA. While Part 11 focuses primarily on access controls, audit trails, and electronic signature validation, the underlying data integrity principle it enforces is directly relevant to network security: regulated electronic records must be maintained in a way that prevents unauthorized access and ensures data authenticity.

Accessing regulated electronic records over unencrypted connections creates an exposure to man-in-the-middle attacks that could theoretically allow modification of data in transit — a scenario that directly threatens the data integrity guarantees Part 11 requires. In practice, EDC systems use HTTPS to encrypt application-layer data, but additional encryption at the network level provides defense in depth and ensures that network-layer attacks cannot compromise the integrity of transmitted records.

Sponsors and CROs that include VPN requirements in their remote access policies for 21 CFR Part 11-regulated systems are addressing this layer explicitly. For independent study coordinators and researchers, documenting VPN use as part of a personal data security practice is consistent with GCP principles of maintaining appropriate data security measures.

ICH GCP E6(R3) and Remote Data Access

The updated ICH E6(R3) guideline, which took effect in 2024, specifically addresses risk-based approaches to clinical trial management and includes guidance on remote monitoring and access to source data. GCP principles require that appropriate safeguards be in place to protect confidentiality and prevent unauthorized access to trial data.

E6(R3) Section 5.5 addresses sponsor oversight of data systems and requires that access controls and security measures appropriate to the risk of the data being handled are in place. For remote access to EDC systems and source documents, this includes encrypted connections — a requirement that extends to study coordinators and CRAs accessing data from remote locations on behalf of the sponsor.

CROs and sponsors that have received FDA inspection notices in recent years have increasingly been asked about remote access security controls, particularly in the context of decentralized trials where more data is accessed remotely. Documented VPN use for EDC and eTMF access is a verifiable control that addresses this inspection concern.

The Home Office and Hotel Risk

Clinical research has always involved travel — CRAs conducting site visits, protocol training, and monitoring visits — but the normalization of remote and hybrid trial models has extended the range of locations from which study data is accessed. A CRA monitoring a site remotely may do so from their home office or from a hotel room near the clinical site.

The security risks in both environments are well-documented:

• Home networks — shared with household devices, typically without enterprise security controls, potentially accessible to guests and IoT devices with unpatched firmware
• Hotel Wi-Fi — shared infrastructure with unknown co-tenants, subject to the captive portal and network manipulation attacks recently documented in the Microsoft/CaptiveCrunch hotel Wi-Fi campaign (August 2026)
• Academic institutional networks — shared across departments, potentially with limited segmentation between research networks and general campus networks

CyberFence's auto-connect feature ensures that EDC sessions, rSDV connections, and safety database access are encrypted regardless of which network is in use, without requiring manual activation before each session.

EDC System Credentials and Audit Trail Integrity

EDC credentials are high-value targets in clinical trial environments. A compromised set of study coordinator credentials provides access not just to one subject's records but to the complete enrolled population — potentially thousands of subjects across multiple sites. In regulated clinical research, unauthorized access to EDC records triggers mandatory audit trail review, sponsor notification, and potentially regulatory reporting.

Credential theft via phishing — fake EDC login pages, fake sponsor IT portals, fake CRO help desks — is a documented threat to clinical research organizations. CyberFence's Web Shield DNS filtering blocks known phishing domains before the browser loads the page, protecting EDC credentials from the most common theft vector. The same Web Shield protection that blocks vishing attackers' AiTM portals (as documented in the UNC6671 campaign targeting financial firms) applies equally to clinical research credential theft attempts.

What CyberFence Provides for Clinical Research Professionals

• AES-256-GCM encryption on every connection — home offices, hotel stays during site visits, academic networks, research facilities
• Auto-connect on untrusted networks — EDC sessions are encrypted before any subject data leaves the device
• Web Shield DNS filtering — blocks phishing domains targeting EDC platforms, sponsor portals, and CRO help desk impersonation sites
• Zero-log policy — no activity records; supports HIPAA minimum necessary principle and trial data confidentiality obligations
• US-operated infrastructure — data stays under US law; relevant for HIPAA and FDA Part 11 compliance documentation
• All devices covered — protect the laptop, tablet, and phone used for EDC access and study communications under one plan

Clinical research runs on trust: trust between sponsors, sites, participants, and regulators that data is handled with integrity and appropriate security. For researchers who access trial data from the range of environments that modern decentralized and hybrid trials require, a VPN that encrypts every connection automatically is the foundational security control that makes that trust defensible.

Want to go deeper? Read how CyberFence protects other regulated industries , the CyberFence Teams product page , or CyberFence plans and pricing .